Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Ziopharm : Hopeful On STS Data

I guess the long running battle between the longs and the shorts will soon come to a conclusion. Options trading on Fri. was very interesting to say the least. PICASSO III (NYSEMKT:STS) results out this week. I am hopeful that PALI can generate 3 months PFS and a clean safety profile. That should be enough to partner and eventually garner approval.

Longer term, SCLC trial will Pali will have an interim check in(approx.) December.

Long and Hopeful

Disclosure: I am long ZIOP, CRMD.